| McChargue et al.3
|
HADS, SES & Karnofsky. 113 people. Randomized. |
97% were Caucasian; 63% earned more than 40.000 U$; 42.5% high school or college; 69.9% were married. |
50.4% of females were in menopause and above weight, Staging: I (29%), II (57%), III (14%). |
Adhesion to relaxation technique (58-70%). Sleep disorders, pain and anxiety significantly decreased. |
| Kwekkeboom et al.4
|
VAS, BPI, BFI, PSQI, ASI & Profile of Mood States - short form. 78 participants. |
67% females, 100% were not Latin or Hispanic; 96% Caucasian; 60% college. |
49% with gynecological cancer; 70% chemotherapy, 98% dizziness, 77% oblivion, 72% dry mouth; 58% opioids, 74% steroids, 86% antiemetics. |
Behavioral therapy was used in average 13.65 times. There has been improvement of pain, fatigue and sleep in the intervention group. |
| Lee et al.5
|
SAI, perception of relaxation treatment. Electroencephalogram. 43 patients. Randomized. |
Age between 27 and 65 years, mean control group age (MC) 49.3 years and intervention (PMR) 51.3 years. |
Fortecortin (MC=21, PMR=20), 39 Granisetron (MC=21, PMR=18), Aprepitant (MC=16, PMR=14). |
Both MC and PMR groups have shown significant improvement in physical health and psychological status, such as anxiety. Listening to recorded MC sounds and practice PMR is useful for gynecological cancer patients during chemotherapy. |
| Demiralp, Oflaz, Komurcu6
|
PSQI, The Piper Fatigue Scale. 27 individuals. |
No demographic data of the study. |
No clinical data of the study |
PMR intervention group had improved sleep quality and fatigue. |
| Haase et al.7
|
VAS 74 randomized patients. |
Age 54-76 years, 62% were females. |
Staging: I (35%), II (26%), III (30%). 68% had stomas. |
79% admitted the benefits of interventions. However both guided image and relaxation had positive responses but without clinical relevance. |
| Singh et al.8
|
VASD, STAI, measurement of vital signs. 82 randomized patients. |
Mean age 63 years, 70% of males in intervention groups. |
No details, just class of drugs used. |
Music is more effective for dyspnea and anxiety because it is easier to apply. |
| Kwekkeboom, Wanta & Bumpus9
|
Imaging Ability Questionnaire, Wisconsin Experience Questionnaire, The Outcome Expectancy Scale, The Edmonton Symptom Assessment System. 40 patients |
Ages (M±16.44). Higher number of males has not completed the study (34%). |
Patients admitted for at least 2 days with pain equal to or above 2 in the last 24 hours. |
Images, PMR and analgesics may be beneficial to treat acute or episodic pain in some patients. |
| Kwekkeboom et al.10
|
NRS, Perception of therapy used. 26 patients. Randomized. |
Age 18 to 72 years (M=43, SD=16); 16 were females, 62% Caucasian; 85% education level above high school. |
77% had malignant hematologic disease; 69% received chemotherapy or radiotherapy; somatic pain (69%); 69% used morphine, hydromorphine, fentanyl or methadone. |
There have been changes in pain scores: effective intervention influenced by active development during intervention. |
